Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real-life study
暂无分享,去创建一个
S. Dragonieri | G. E. Carpagnano | L. Iannuzzi | N. Quaranta | E. Buonamico | A. Portacci | C. Santomasi
[1] S. Stanojevic,et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests , 2021, European Respiratory Journal.
[2] M. D’Amato,et al. Benralizumab effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicentre Study. , 2021, The journal of allergy and clinical immunology. In practice.
[3] Hirofumi Watanabe,et al. Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients , 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.
[4] O. Resta,et al. Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab. , 2021, Journal of biological regulators and homeostatic agents.
[5] G. Canonica,et al. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. , 2020, The Lancet. Respiratory medicine.
[6] A. Douiri,et al. Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma. , 2020, Chest.
[7] N. Lombardo,et al. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma , 2020, International journal of immunopathology and pharmacology.
[8] G. Passalacqua,et al. Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis. , 2020, Respiratory medicine.
[9] Luo Zhang,et al. Understanding the Role of Neutrophils in Refractoriness of Chronic Rhinosinusitis With Nasal Polyps , 2019, Allergy, asthma & immunology research.
[10] G. Passalacqua,et al. Severe asthma, biologicals, and auto‐injection: Yes, no, may be! , 2020, Allergy.
[11] C. Janson,et al. Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden , 2019, Allergy.
[12] M. Cazzola,et al. Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma , 2017, Expert opinion on drug metabolism & toxicology.
[13] K. Rabe,et al. Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma , 2017, The New England journal of medicine.
[14] N. Quaranta,et al. Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach , 2017, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.
[15] W. Busse,et al. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial , 2016, The Lancet.
[16] S. Fujieda,et al. Association and management of eosinophilic inflammation in upper and lower airways. , 2015, Allergology international : official journal of the Japanese Society of Allergology.
[17] J. Ma,et al. Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non‐eosinophilic, chronic rhinosinusitis with nasal polyps , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] T. To,et al. Describing and Quantifying Asthma Comorbidty: A Population Study , 2012, PloS one.
[19] C. Papadakis,et al. The effect of functional endoscopic sinus surgery on patients with asthma and CRS with nasal polyps. , 2010, Rhinology.
[20] M. Gelardi,et al. Cytology in the diagnosis of rhinosinusitis , 2007, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[21] M. Seybt,et al. The Prevalence and Effect of Asthma on Adults with Chronic Rhinosinusitis , 2007, Ear, nose, & throat journal.
[22] ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. , 2005, American journal of respiratory and critical care medicine.
[23] C. Bachert,et al. Enhanced soluble interleukin‐5 receptor alpha expression in nasal polyposis , 2003, Allergy.
[24] D. Kennedy,et al. Staging for Rhinosinusitis , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[25] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[26] P. Clement,et al. The diagnostic value of a cytogram in rhinopathology. , 1981, Rhinology.